期刊
MICROBES AND INFECTION
卷 11, 期 10-11, 页码 835-841出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.micinf.2009.04.024
关键词
Enterohemorrhagic Escherichia coli; Trivalent subunit vaccine; Intimin; Shiga toxin; E. coli secreted protein A
资金
- National High Technology Research and Development Program of China [2006AA02Z443, 2007AA02Z409]
- National Natural Science Foundation of China [30770514, 30670107]
Enterohemorrhagic Escherichia coli (EHEC) is an important food-borne pathogen, which causes a wide spectrum of diseases ranging from hemorrhagic colitis to life-threatening hemolytic uremic syndrome (HUS). Currently, insufficient measures to prevent and treat EHEC infection make a vaccine against EHEC in great demand. EspA (E. coli secreted protein A), intimin, and Stx2 (Shiga toxin 2) are three predominant virulence factors of EHEC, and each of them has proved to be capable of inducing partial protective immunity. In this study, we constructed a trivalent recombinant protein designated EIS that is composed of EspA (E), C-terminal 300 amino acids of intimin (1) and B subunit of Stx2 (S), and tested it as vaccine using a mouse model. Our results showed that immunization of EIS induced strong humoral response to EspA, intimin and Stx2 and protected mice against the challenges with live EHEC or EHEC sonicated lysate. Moreover, it enhanced clearance of intestinally colonized bacteria. This work suggests that for EHEC vaccines using a combination of EspA, intimin and Stx2 antigens appears to be more effective than using any of these immunogens alone. (C) 2009 Elsevier Masson SAS. All fights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据